Recursion Pharmaceuticals Q2 EPS $(0.31) Up From $(0.88) YoY

Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.31) per share. This is a 64.77 percent increase over losses of $(0.88) per share from the same period last year.

Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.31) per share. This is a 64.77 percent increase over losses of $(0.88) per share from the same period last year.

Total
0
Shares
Related Posts